GET THE APP
Aspirin New Findings Journals | Open Access Journals
Cardiovascular Diseases & Diagnosis

Cardiovascular Diseases & Diagnosis

ISSN: 2329-9517

Open Access
Spanish Chinese Russian German French Japanese Portuguese Hindi Telugu Tamil
Submit Manuscript arrow_forward arrow_forward ..

Aspirin New Findings Journals

Aspirin is a well-established therapy for the secondary prevention of cardiovascular events. However, its role in the primary prevention of cardiovascular disease is unclear, especially in older people, who are at increased risk. From 2010 to 2014, we enrolled community-living men and women in Australia and the United States who were 70 years of age or older (or ≥65 years of age among blacks and Hispanics in the United States) and had no cardiovascular disease, dementia, or disability . Participants were randomly assigned to receive either enteric-coated aspirin 100 mg or placebo. The primary end point was a compound of death, dementia, or persistent physical disability; The results of this endpoint are reported in another journal article. Secondary endpoints included major bleeding and cardiovascular disease (defined as fatal coronary heart disease, non-fatal myocardial infarction, fatal or non-fatal stroke, or hospitalization for heart failure).

High Impact List of Articles
Conference Proceedings

Relevant Topics in Medical Sciences

Awards & Nominations

50+ Million Readerbase

Journal Highlights

Google Scholar citation report
Citations: 427

Cardiovascular Diseases & Diagnosis received 427 citations as per Google Scholar report

Citation image
Cardiovascular Diseases & Diagnosis peer review process verified at publons
Publon image

Indexed In

Related Links

PMC/PubMed Indexed Articles
Abdominal Aortic Aneurysm Type II Endoleaks.
A Historical Perspective on Presentations of Hypertensive Acute Heart Failure

View More »

 

Open Access Journals

arrow_upward arrow_upward